Roth Capital Remains Positive on Keryx (KERX) Following Q3 Results, Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. SPCX
7. AVGO
8. BABA
9. HD
10. BJ

Go back to Roth Capital Remains Positive on Keryx (KERX) Following Q3 Results, Update

Keryx Biopharma (KERX) Misses Q3 EPS by 11c

November 6, 2014 7:01 AM EST

Keryx Biopharma (NASDAQ: KERX) reported Q3 EPS of ($0.38), $0.11 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $256 thousand versus the consensus estimate of $150 thousand.

For earnings history and earnings-related data on Keryx Biopharma (KERX) click here.

... More